<code id='B20A7A01F1'></code><style id='B20A7A01F1'></style>
    • <acronym id='B20A7A01F1'></acronym>
      <center id='B20A7A01F1'><center id='B20A7A01F1'><tfoot id='B20A7A01F1'></tfoot></center><abbr id='B20A7A01F1'><dir id='B20A7A01F1'><tfoot id='B20A7A01F1'></tfoot><noframes id='B20A7A01F1'>

    • <optgroup id='B20A7A01F1'><strike id='B20A7A01F1'><sup id='B20A7A01F1'></sup></strike><code id='B20A7A01F1'></code></optgroup>
        1. <b id='B20A7A01F1'><label id='B20A7A01F1'><select id='B20A7A01F1'><dt id='B20A7A01F1'><span id='B20A7A01F1'></span></dt></select></label></b><u id='B20A7A01F1'></u>
          <i id='B20A7A01F1'><strike id='B20A7A01F1'><tt id='B20A7A01F1'><pre id='B20A7A01F1'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:2
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Some top drug companies are starting to take action on climate
          Some top drug companies are starting to take action on climate

          AdobeThisarticleisadaptedfromSTAT’sexclusiveanalysisintheSTATReport: “Climaterankings:Howtopdrugcomp

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Setback for rare diseases as Taysha Gene Therapies pulls back

          AdobeIn2020,asbiotechstockssurgedamidthepandemic,astartupcalledTayshaGeneTherapiesraisedover$300mill